View the MONVEX-L registration information details.
Back to drug list
ItemsDrug Registration information
ID2530
No2530
Brand NameMONVEX-L
IngredientsLevocetirizine Dihydrochloride USP 5 mg, Montelukast Sodium Eq. to. Montelukast BP 10 mg
Dosage FormFilm coated Tablets
Primary PackagingAlu-Alu Blister
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 3 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
Indicationsfor the relief of symptoms associated with seasonal and perennial allergic rhinitis.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionA yellow colored, round shaped, biconvex, film Coated tablet, plain on both side.
Note
License OwnerVE PRODUCTS (LAO) CO.,LTD
Manufacturer4Care Lifescience Pvt. Ltd.
CountryINDIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No12 I 5835/24
FDD Registration Date30/12/2024
Expiry Date29/12/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA